Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting

导出原文传递

翻译打印收藏纠错

作者： Wang, Tiansheng ^[1] ; Lu, Wenchao ^[2] ; Li, Dandan ^[3] ; Tang, Huilin ^[4] ; Yang, Jeff Y. ^[5] ; Buse, John B. ; Sturmer, Til

作者单位： Capital Med Univ, Beijing Friendship Hosp, Dept Pharm, Beijing, Peoples R China ^[1] Peking Univ, Hlth Sci Ctr, Inst Drug Evaluat, Beijing, Peoples R China ^[2] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27515 USA ^[3] Capital Med Univ, Peking Univ, Beijing Shijitan Hosp, Dept Pharm,Sch Clin Med 9, Beijing, Peoples R ^[4] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA ^[5]

发布时间 2019-12-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Diabetes care

2019年42卷6期

E89-E91页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting

Diabetes care

相似文献

Diabetes care

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting

Diabetes care

相似文献

Diabetes care

相关期刊

检索历史清除